Research by Isabelle Gagnon-Arpin

(Displaying 1 to 8 of 8)
This was a free webinar.Cardiovascular disease (CVD) prevalence incurs significant costs to governments and society in the form of hospitalizations, disease management, and lost...
The Conference Board of Canada | Recorded Webinar | July 2017 | by Isabelle Gagnon-Arpin
The scope of pharmacy services has expanded in many Canadian jurisdictions in recent years, with each province and territory taking a different approach to optimize these changes...
The Conference Board of Canada | Recorded Webinar | July 2017 | by Isabelle Gagnon-Arpin
This report examines the savings generated by increasing access to a new medication category—proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9i)—which effectively...
The Conference Board of Canada | 69 pages | April 2017 | by Isabelle Gagnon-Arpin, Greg Sutherland
Ce rapport examine les économies générées par le recours accru à une nouvelle catégorie de médicaments – les inhibiteurs de la proprotéine convertase subtilisine/kexine de type...
Le Conference Board du Canada | 75 pages | April 2017 | by Isabelle Gagnon-Arpin, Greg Sutherland
The scope of pharmacy services has expanded in many Canadian jurisdictions in recent years. This report estimates the health and economic impact of three community pharmacy services...
The Conference Board of Canada | 106 pages | April 2017 | by Isabelle Gagnon-Arpin, Alexandru Dobrescu, Greg Sutherland, Carole Stonebridge, Thy Dinh
Ces dernières années, l’éventail des services dispensés en pharmacie a été élargi dans un grand nombre d’administrations provinciales et territoriales du Canada. Ce rapport présente...
Le Conference Board du Canada | 111 pages | April 2017 | by Isabelle Gagnon-Arpin, Alexandru Dobrescu, Greg Sutherland, Carole Stonebridge, Thy Dinh
This report examines the economic impact of switching three categories of drugs from prescription to over the counter, and the impact on stakeholders including private insurers,...
The Conference Board of Canada | 82 pages | March 2017 | by Isabelle Gagnon-Arpin
Le présent rapport examine les incidences économiques de la mise en vente libre de trois catégories de médicaments et ses effets sur les intervenants, à savoir les assureurs privés,...
Le Conference Board du Canada | 85 pages | March 2017 | by Isabelle Gagnon-Arpin
(Displaying 1 to 8 of 8)